Chitosan and its derivatives have been increasingly used for bacteriostasis. To date, the effect of chitosan and N‑(2‑hydroxyl) propyl‑3‑trimethyl ammonium chitosan chloride (HTCC) on Enterococcus faecalis (E. faecalis) associated with endodontic infection has remained to be determined. Chitosan and HTCC were serially diluted with double‑distilled water (DDW) or PBS at concentrations of 20‑2,500 µg/ml. Various strains of E. faecalis (American Type Tissue Collection no. 29212, as well as isolated strains P25RC and P52Sa) in plankton were adjusted to an optical density at 600 nm of 0.10 and treated with chitosan or HTCC. A colony‑forming unit assay was used to determine the concentration of residual bacteria after treatment. Furthermore, E. faecalis biofilms were cultured on coverslips and treated with chitosan or HTCC. The coverslips were rinsed, stained using Live/dead® BacLight™ bacterial viability kit and observed under an inverted fluorescence microscope. In addition, biofilms on dentine blocks were prepared and observed under a scanning electron microscope. MC3T3‑E1 pre‑osteoblasts were seeded on 96‑well plates and treated with chitosan or HTCC at various concentrations. The cytotoxicity of chitosan and HTCC on MC3T3‑E1 pre‑osteoblasts was detected using a Cell Counting Kit‑8 assay after 24, 48 and 72 h of treatment. The results revealed that the final minimum bactericidal concentrations (MBC) of chitosan and HTCC dissolved in DDW were 70 and 140 µg/ml, respectively. Chitosan and HTCC in DDW exerted a significantly greater antibacterial effect as compared with that in PBS (P<0.05). At the MBC, chitosan and HTCC in DDW, but particularly chitosan, had a significant antibacterial effect on E. faecalis biofilm. Chitosan exhibited no cytotoxicity to MC3T3‑E1 pre‑osteoblasts at a concentration of <625 µg/ml, while HTCC inhibited the proliferation of the cells in the concentration range of 39‑10,000 µg/ml. In conclusion, chitosan and HTCC exhibited prominent antibacterial properties on E. faecalis in the planktonic state and as a biofilm via charge interaction, indicating their potential for application in root canal disinfection and fillings.
Intraoral wounds face unique challenges, including a humid microenvironment, mechanical stress, and microbial colonization, complicating healing. Local and systemic factors further impair regeneration. Biomaterials with tailored mechanical properties, antibacterial activity, and bioactivity show promise in promoting mucosal repair and bone regeneration. However, dynamic microenvironment adaptation and multifunctional integration remain unmet needs. This review provides an integrative overview of the latest advancements in biomaterials for intraoral wound healing. We discuss the physiological mechanisms of intraoral wound healing, key influencing factors. Additionally, we explore the idea properties of biomaterials and their applications in various intraoral wound scenarios and highlight future directions in biomaterial development to guide clinical practice and research.
17 June 2025 in Colloids and Surfaces B: Biointerfaces
Chemotherapy-induced oral mucositis is a common complication in cancer therapy. Multiple studies demonstrate that doxepin mouthwash is effective in controlling CIOM pain, while research on its ulcer healing effects and underlying mechanisms remains limited. Additionally, local adhesive formulations of doxepin for oral application are still lacking. In this study, we developed a bilayer oral patch using 3D-printing technology for the localized sustained release of doxepin hydrochloride. This patch demonstrated favorable characteristics, including thinness, flexibility, and excellent mucosal adhesion, while promoting ulcer healing in CIOM animal models. Further investigation revealed that the healing mechanism involves the alleviation of oxidative stress and attenuation of excessive inflammatory responses. The doxepin hydrochloride patch developed in this study provides a novel pharmaceutical option for clinical management of CIOM.